BiotechTube
Home/Prenostics/Sarah Blagden
SB

Sarah Blagden

Co-Founder & Chief Scientific Officer

Prenostics

Therapeutic Areas

Oncology

Prenostics Pipeline

DrugIndicationPhase
Prenostics TestEarly Detection (Stage 0-2) - Ovarian Cancer in high-risk womenPre-clinical

Leadership Team at Prenostics

ML
Mitch Levine
Chief Executive Officer
LH
Lyndal Hesterberg
Technology Lead
View full Prenostics profile